Swanbio Therapeutics Limited

Active10942620 Private limited company
Incorporated
1 September 2017 (9 years)
Previously known as
Avistat Bio Limited (until 8 December 2017)
Avalon Bio Limited (until 24 October 2017)
This list may be incomplete. See all names on Companies House
Industry
Research and experimental development on biotechnology (72110)
Accounts type
Audit exemption subsidiary
Region
East of England
Address
Sycamore House
Gunnels Wood Road
Stevenage
SG1 2BP

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
14 September 2027
Last conf. stmt
31 August 2026

Officers

This list may be incomplete. See all officers on Companies House

Officer details are public data from the Companies House register.

Mccorkle Iv, Pope "Chip"
Secretary · Appointed 12 August 2024
Director · Appointed 14 March 2024
American
Born February 1968 (58)
Director · Appointed 14 March 2024
American
Born April 1970 (56)
Officer history (12 former)
31 July 2026
Resigned Parini, Michael John as Director
12 August 2024
Appointed Mccorkle Iv, Pope "Chip" as Secretary
14 March 2024
Resigned Lawton, Alison as Director
14 March 2024
Appointed Bircher Iii, James Albert as Director
14 March 2024
Appointed Schneider, Paul Matthew as Director
14 March 2024
Resigned Anderson, Thomas D. as Director
14 March 2024
Resigned Tsai, John, Dr as Director
14 March 2024
Appointed Parini, Michael John as Director
14 March 2024
Resigned Allen, Patricia as Director
14 March 2024
Resigned Hamilton, Alexander Brian as Director
10 October 2023
Resigned Knowles, Julius John Sheldon as Director
10 October 2023
Resigned Hollowood, Christopher John, Dr as Director
10 October 2023
Appointed Tsai, John, Dr as Director
20 August 2021
Appointed Hamilton, Alexander Brian as Director
20 August 2021
Appointed Allen, Patricia as Director
4 January 2021
Appointed Lawton, Alison as Director
22 December 2020
Resigned Bar-Zohar, Danny as Director
23 June 2020
Appointed Bar-Zohar, Danny as Director
14 March 2020
Resigned Prener, Anne as Director
30 September 2019
Resigned Papapetropoulos, Spyridon as Director
31 July 2019
Appointed Anderson, Thomas D. as Director
22 April 2019
Appointed Papapetropoulos, Spyridon as Director
6 December 2018
Resigned Salzman, Rachel Lynn as Director
19 October 2018
Appointed Prener, Anne as Director
2 February 2018
Appointed Hollowood, Christopher John, Dr as Director
2 February 2018
Appointed Knowles, Julius John Sheldon as Director
1 September 2017
Appointed Salzman, Rachel Lynn as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 19 March 2024
Owns 75–100% of shares
Holds 25–50% of voting rights
Right to appoint and remove directors
Private Limited Company
Reg. no. 15295548
Former controllers (4)
19 March 2024
Ceased Syncona Limited — Owns 50–75% of shares
2 February 2018
Ceased Rachel Lynn Salzman — Owns 25–50% of shares
2 February 2018
Ceased Florian Sebald Eichler — Owns 25–50% of shares
2 February 2018
Ceased Karen Fran Kozarsky — Owns 25–50% of shares

Group structure 5 companies

Ownership group derived from the Companies House PSC register

Freeline Therapeutics Holdings Limited DissolvedOwns 75–100% of shares
Freeline Holdings (UK) Limited DissolvedOwns 75–100% of shares
Spur Therapeutics Limited Owns 75–100% of shares
Swanbio Therapeutics Limited This company Owns 75–100% of shares

Financials

Net Assets
£1,365,849
down £7,814,864 (85%)
Employees
6
up 2 (50%)
Current Ratio
1.1x

Trend

Net Assets
£0 £5.0M £10.0M £15.0M 2019 2020 2021 £11,363,643 £9,180,713 £1,365,849
Balance sheet detail
202120202019
Fixed Assets£0
Current Assets£13,481,467£12,138,285£12,664,450
Creditors (< 1 year)£12,115,618£2,957,572£1,300,807
Net Current Assets£1,365,849£9,180,713£11,363,643
Net Assets£1,365,849£9,180,713£11,363,643
Shareholder Funds£1,365,849£9,180,713£11,363,643

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
26 October 2026Other filing
26 October 2026Accounts filing
26 October 2026Other filing
26 October 2026Audit exemption subsidiary accounts31 December 2025
3 September 2026Confirmation statement with updates31 August 2026
Show all recent filings

Some other companies at this address

Other companies in this industry

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?